PFIZER INC Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Pfizer Inc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Pfizer Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 29, 2024 was $4.31B.
  • Pfizer Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending September 29, 2024 was $4.25B, a 60.4% decline year-over-year.
  • Pfizer Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $2.46B, a 91.5% decline from 2022.
  • Pfizer Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $29B, a 35.4% increase from 2021.
  • Pfizer Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $21.4B, a 122% increase from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.25B $4.31B +$6.56B Jul 1, 2024 Sep 29, 2024 10-Q 2024-11-04
Q2 2024 -$2.31B -$17M -$2.53B -101% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $223M $3.32B -$2.24B -40.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $2.46B -$3.36B -$8.28B -168% Oct 2, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $10.7B -$2.25B -$9.75B -130% Jul 3, 2023 Oct 1, 2023 10-Q 2024-11-04
Q2 2023 $20.5B $2.51B -$6.43B -71.9% Apr 3, 2023 Jul 2, 2023 10-Q 2024-08-05
Q1 2023 $26.9B $5.56B -$2.05B -26.9% Jan 1, 2023 Apr 2, 2023 10-Q 2024-05-08
Q4 2022 $29B $4.92B +$1.77B +56.3% Oct 3, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $27.2B $7.5B +$247M +3.4% Jul 4, 2022 Oct 2, 2022 10-Q 2023-11-08
Q2 2022 $26.9B $8.94B +$3.47B +63.5% Apr 4, 2022 Jul 3, 2022 10-Q 2023-08-09
Q1 2022 $23.5B $7.6B +$2.08B +37.7% Jan 1, 2022 Apr 3, 2022 10-Q 2023-05-10
Q4 2021 $21.4B $3.15B +$1.5B +91.2% Oct 4, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $19.9B $7.26B +$4.49B +162% Jul 5, 2021 Oct 3, 2021 10-Q 2022-11-09
Q2 2021 $15.4B $5.47B +$2.16B +65% Apr 5, 2021 Jul 4, 2021 10-Q 2022-08-10
Q1 2021 $13.2B $5.52B +$3.61B +189% Jan 1, 2021 Apr 4, 2021 10-Q 2022-05-11
Q4 2020 $9.64B $1.65B +$1.82B Sep 28, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $7.82B $2.77B -$4.65B -62.7% Jun 29, 2020 Sep 27, 2020 10-Q 2021-11-12
Q2 2020 $12.5B $3.31B -$1.12B -25.3% Mar 30, 2020 Jun 28, 2020 10-Q 2021-08-12
Q1 2020 $13.6B $1.91B -$2.32B -54.8% Jan 1, 2020 Mar 29, 2020 10-Q 2021-05-13
Q4 2019 $15.9B -$177M +$1.08B +85.9% Sep 30, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $14.8B $7.42B +$3.72B +100% Jul 1, 2019 Sep 29, 2019 10-Q 2020-11-05
Q2 2019 $11.1B $4.43B +$1.16B +35.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $9.95B $4.24B +$756M +21.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $9.2B -$1.25B -$13.4B -110% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $22.6B $3.7B -$157M -4.07% Jul 2, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $22.7B $3.27B -$216M -6.2% Apr 2, 2018 Jul 1, 2018 10-Q 2019-08-08
Q1 2018 $22.9B $3.48B -$83M -2.33% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-09
Q4 2017 $23B $12.1B +$14.2B Oct 2, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $8.86B $3.86B +$1.83B +89.8% Jul 3, 2017 Oct 1, 2017 10-Q 2018-11-08
Q2 2017 $7.03B $3.49B +$810M +30.3% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-09
Q1 2017 $6.22B $3.56B +$523M +17.2% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-10
Q4 2016 $5.7B -$2.05B -$1.52B -291% Oct 3, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $7.23B $2.03B +$551M +37.2% Jul 4, 2016 Oct 2, 2016 10-Q 2017-11-09
Q2 2016 $6.67B $2.68B +$13M +0.49% Apr 4, 2016 Jul 3, 2016 10-Q 2017-08-10
Q1 2016 $6.66B $3.04B +$1.91B +168% Jan 1, 2016 Apr 3, 2016 10-Q 2017-05-11
Q4 2015 $4.76B -$523M +$2.1B +80% Sep 28, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 $2.66B $1.48B -$870M -37% Jun 29, 2015 Sep 27, 2015 10-Q 2016-11-10
Q2 2015 $3.53B $2.66B -$487M -15.5% Mar 30, 2015 Jun 28, 2015 10-Q 2016-08-11
Q1 2015 $4.01B $1.13B -$1.08B -48.7% Jan 1, 2015 Mar 29, 2015 10-Q 2016-05-12
Q4 2014 $5.09B -$2.62B -$8.27B -146% Sep 29, 2014 Dec 31, 2014 10-K 2017-02-23
Q3 2014 $13.4B $2.35B -$321M -12% Jun 30, 2014 Sep 28, 2014 10-Q 2015-11-05
Q2 2014 $13.7B $3.15B -$10.6B -77.1% Mar 31, 2014 Jun 29, 2014 10-Q 2015-08-06
Q1 2014 $24.3B $2.21B -$338M -13.3% Jan 1, 2014 Mar 30, 2014 10-Q 2015-05-07
Q4 2013 $24.7B $5.65B -$362M -6.02% Sep 30, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $25B $2.67B -$891M -25% Jul 1, 2013 Sep 29, 2013 10-Q 2014-11-06
Q2 2013 $25.9B $13.8B +$12.9B +1490% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $13B $2.55B +$247M +10.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $12.7B $6.02B +$7.49B Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $5.26B $3.56B +$83M +2.39% Jul 2, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $5.17B $867M -$2.85B -76.6% Apr 2, 2012 Jul 1, 2012 10-Q 2013-08-09
Q1 2012 $8.02B $2.3B -$1.3B -36.1% Jan 1, 2012 Apr 1, 2012 10-Q 2013-05-10
Q4 2011 $9.32B -$1.47B -$4.62B -147% Oct 3, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $13.9B $3.48B +$1.91B +121% Jul 4, 2011 Oct 2, 2011 10-Q 2012-11-09
Q2 2011 $12B $3.71B +$3.7B +37020% Apr 4, 2011 Jul 3, 2011 10-Q 2011-08-11
Q1 2011 $8.34B $3.6B +$4.07B Jan 1, 2011 Apr 3, 2011 10-Q 2012-05-10
Q4 2010 $4.27B $3.15B Oct 4, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $1.57B Jul 5, 2010 Oct 3, 2010 10-Q 2011-11-10
Q2 2010 $10M Apr 5, 2010 Jul 4, 2010 10-Q 2011-08-11
Q1 2010 -$468M Jan 1, 2010 Apr 4, 2010 10-Q 2011-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.